An Efficacy and Safety Study of Hydromorphone Hydrochloride (HCl) Oral Osmotic System (OROS) in the Reduction of Breakthrough Pain Medication Frequency in Participants With Cancer

NCT01006356 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

141

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer
Pain

Interventions

DRUG: Hydromorphone HCl OROS

Sponsor

Janssen Korea, Ltd., Korea